From Medscape Oncology

Coverage from the

International Waldenstrom's Macroglobulinemia Foundation (IWMF) 2019 Forum

June 07 - 09, 2019; Philadelphia, Pennsylvania

June 07 - 09, 2019 Philadelphia, Pennsylvania
  • IWMF 2019 New Lymphoma Drugs Build on BTK Inhibitor Success Life expectancy for patients with Waldenstrom's macroglobulinemia has improved considerably in the past decade, and new treatments on the horizon could mean that trend continues.

Conference News

Popular News From 2018

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage